Detalhe da pesquisa
1.
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
N Engl J Med
; 384(2): 117-128, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200892
2.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
N Engl J Med
; 384(2): 129-139, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200891
3.
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
Neuroendocrinology
; 112(3): 298-310, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33940581
4.
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment.
Diabetes Obes Metab
; 23(12): 2632-2642, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338408
5.
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
N Engl J Med
; 377(24): 2337-2348, 2017 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28899222
6.
Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2.
Diabetes Obes Metab
; 22(11): 2089-2096, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618383
7.
TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.
Oncologist
; 24(11): 1446-1452, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189618
8.
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome.
Oncologist
; 24(8): e662-e670, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651397
9.
Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis.
Future Oncol
; 15(12): 1397-1406, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734573
10.
Economic analysis of inadequate symptom control in carcinoid syndrome in the United States.
Future Oncol
; 14(23): 2361-2370, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30095284
11.
A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin.
Clin Pharmacol Ther
; 115(6): 1383-1390, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456487
12.
Clopidogrel with or without omeprazole in coronary artery disease.
N Engl J Med
; 363(20): 1909-17, 2010 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20925534
13.
Telotristat ethyl reverses myxomatous changes in mice mitral valves.
Front Cardiovasc Med
; 9: 945672, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35990981
14.
Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone.
Diabetes Technol Ther
; 23(1): 70-77, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32721228
15.
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome.
J Gastrointest Cancer
; 52(1): 212-221, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32146619
16.
Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study.
Pancreas
; 49(3): 408-412, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132510
17.
Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption.
J Clin Endocrinol Metab
; 105(4)2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837264
18.
Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome.
Cancer Manag Res
; 12: 9713-9719, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33116830
19.
Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies.
Diabetes Care
; 43(11): 2713-2720, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928957
20.
Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study.
Cancer Manag Res
; 12: 6607-6614, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801896